Abstract
Background
We have entered an era of renewed interest in novel approaches to surgical intervention and minimally invasive and transcatheter technique. With an aging population, isolated tricuspid valve regurgitation incidence is rising; however, referral for surgical intervention remains low.
Aims
We undertook this retrospective review to assess outcomes and challenges associated with tricuspid valve intervention.
Methods
A comprehensive retrospective review of all patients undergoing tricuspid valve intervention in our institution between 2004 and 2018 was carried out.
Results
A total of 259 patients who underwent a tricuspid intervention between 2004 and 2018 were identified. Of those, 229 underwent a repair and 30 underwent a replacement. Median survival for repair was 3124 days, and replacement was 2294 days. In-patient mortality was 12% for those undergoing repair and 7% for the replacement patients. Of those undergoing redo tricuspid valve intervention, eight patients (61.5%) were alive at most recent follow-up. Eight patients required intraoperative pacemakers, 2 required postoperative pacemakers. Of those who had intraoperative epicardial pacing systems placed, 5 of the 8 remained pacing dependent on most recent follow up.
Conclusion
Beyond technical challenges, decision making regarding pacemaker requirement requires further exploration. Redo tricuspid valve surgery carries a significant mortality risk and consideration should be given to earlier intervention in this context.
Similar content being viewed by others
Data availability
All source data is available and held in anonymized form by the authors.
Code availability
The software GraphPad Prism 9 for Mac OS version 9.9.0
References
Stuge O, Liddicoat J (2006) Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg 132(6):1258–1261
Alushi B, Vathie K, Thiele H, Lauten A (2020) Transcatheter therapies for severe tricuspid regurgitation. Quo vadis? Herz
Nath J, Foster E, Heidenreich PA (2004) Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43(3):405–409
Starck CT, Kempfert J, Falk V (2015) Tricuspid valve interventions: surgical techniques and outcomes. Euro Intervention. 11 Suppl W:W128–32
Brescia AA, Ward ST, Watt TMF et al (2020) Outcomes of guideline-directed concomitant annuloplasty for functional tricuspid regurgitation. Ann Thorac Surg 109(4):1227–1232
Nishimura RA, Otto CM, Bonow RO et al (2014) AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129(23):2440–2492
Cooper JP, Jayawickreme SR, Swanton RH (1995) Permanent pacing in patients with tricuspid valve replacements. Br Heart J 73(2):169–172
Dhoble A, Zhao Y, Vejpongsa P et al (2019) National 10-year trends and outcomes of isolated and concomitant tricuspid valve surgery. J Cardiovasc Surg (Torino) 60(1):119–127
Hamandi M, George TJ, Smith RL, Mack MJ (2019) Current outcomes of tricuspid valve surgery. Prog Cardiovasc Dis 62(6):463–466
Jeganathan R, Armstrong S, Al-Alao B, David T (2013) The risk and outcomes of reoperative tricuspid valve surgery. Ann Thorac Surg 95(1):119–124
Wang TKM, Griffin BP, Miyasaka R et al (2020) Isolated surgical tricuspid repair versus replacement: meta-analysis of 15 069 patients. Open Heart 7(1):e001227
Koplan BA, Stevenson WG, Epstein LM et al (2003) Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery. J Am Coll Cardiol 41(5):795–801
Mar PL, Angus CR, Kabra R et al (2017) Perioperative predictors of permanent pacing and long-term dependence following tricuspid valve surgery: a multicentre analysis. Europace 19(12):1988–1993
Jokinen JJ, Turpeinen AK, Pitkanen O et al (2009) Pacemaker therapy after tricuspid valve operations: implications on mortality, morbidity, and quality of life. Ann Thorac Surg 87(6):1806–1814
Lin G, Nishimura RA, Connolly HM et al (2005) Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol 45(10):1672–1675
Martins RP, Galand V, Leclercq C, Daubert JC (2018) Cardiac electronic implantable devices after tricuspid valve surgery. Heart Rhythm 15(7):1081–1088
Eleid MF, Blauwet LA, Cha YM et al (2012) Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation. J Am Coll Cardiol 59(9):813–818
Asmarats L, Puri R, Latib A et al (2018) Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol 71(25):2935–2956
Overtchouk P, Piazza N, Granada J et al (2020) Advances in transcatheter mitral and tricuspid therapies. BMC Cardiovasc Disord 20(1):1
Acknowledgements
The authors would like to sincerely thank Ms Anne Gregg for her assistance with data collection.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
Ethics approval was not required for this retrospective study.
Consent to participate
Patient data is anonymized.
Consent for publication
All the authors provided their consent for publication of the manuscript.
Conflict of interest
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
O’Sullivan, K.E., Cull, S., Armstrong, L. et al. Examining the forgotten valve: outcomes of tricuspid valve surgery, a 15-year experience. Ir J Med Sci 191, 699–704 (2022). https://doi.org/10.1007/s11845-021-02608-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-021-02608-0